FDA Issues Final Guidance for Fixed-Combination Hypertension Drugs

Drug Industry Daily
A A
The FDA released final guidance Tuesday for sponsors of fixed-combination hypertension drugs, with several clarifications of the draft document.

To View This Article:

Login

Subscribe To Drug Industry Daily